What is InVision?
InVision offers comprehensive eye and vision care, complemented by occupational therapy services. The company specializes in vision therapy for adults and children addressing conditions such as strabismus, binocular coordination disorders, accommodation and tracking issues, and traumatic brain injuries. Additionally, InVision provides occupational therapy for individuals with injuries, developmental, and neuromotor delays. A key area of focus is myopia control, aiming to slow or delay the onset of nearsightedness. The integration of optometry and occupational therapy provides a unique, comprehensive approach to vision rehabilitation programs, addressing an estimated 20% of children with binocular coordination disorders and associated developmental delays.
How much funding has InVision raised?
InVision has raised a total of $45K across 1 funding round:
Debt
$45K
Debt (2021): $45K with participation from PPP
Key Investors in InVision
PPP
Public-Private Partnership
What's next for InVision?
With the recent capital injection, InVision is poised for significant expansion, likely focusing on scaling its specialized vision therapy and occupational therapy services. The company's strategic direction will probably involve enhancing its myopia control offerings and broadening its reach to serve more adults and children requiring comprehensive vision rehabilitation. Further investment will likely support technological advancements in diagnostic tools and therapeutic interventions, solidifying InVision's position as a leader in integrated eye care and rehabilitation.
See full InVision company page
